Send mail to Author

A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer : results of the PELICAN study (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _  __    _____     _  __    ______    _____    _    _   
 | |/ //  |  ___||  | |/ //  /_   _//  / ____|| | || | || 
 | ' //   | ||__    | ' //    -| ||-  / //---`' | || | || 
 | . \\   | ||__    | . \\    _| ||_  \ \\___   | \\_/ || 
 |_|\_\\  |_____||  |_|\_\\  /_____//  \_____||  \____//  
 `-` --`  `-----`   `-` --`  `-----`    `----`    `---`
 


Back to frontdoor view

OPUS4 Logo